Advertisement
Advertisement
U.S. Markets close in 3 hrs 7 mins
Advertisement
Advertisement
Advertisement
Advertisement

Grifols, S.A. (GRFS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.02+0.04 (+0.45%)
As of 12:46PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close8.98
Open8.97
Bid9.00 x 800
Ask9.01 x 1100
Day's Range8.96 - 9.06
52 Week Range8.29 - 15.90
Volume232,654
Avg. Volume890,267
Market Cap8.685B
Beta (5Y Monthly)0.21
PE Ratio (TTM)16.46
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJun 03, 2021
1y Target EstN/A
  • PR Newswire

    Grifols Procleix Plasmodium Assay receives CE mark, a first for malaria blood screening

    Grifols (MCE: GRF) (MCE: GRF.P) (NASDAQ: GRFS), a global leader in the development of plasma-derived therapies and the development of innovative diagnostic solutions, today announced that its Procleix Plasmodium Assay has obtained the CE mark, the first for an automated nucleic acid test (NAT) system specifically validated for screening blood donors for malaria.

  • GlobeNewswire

    GigaGen Publishes Research Demonstrating the Potential of its Machine Learning Platform to Improve Antibody Drug Discovery and Development

    SOUTH SAN FRANCISCO, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- GigaGen Inc., a biotechnology company advancing transformative antibody drugs for immune deficiencies, infectious diseases and checkpoint resistant cancers, and a subsidiary of Grifols, announced today the publication of a research article titled, “Predicting antibody binders and generating synthetic antibodies using deep learning,” in the peer-reviewed journal mAbs. The article demonstrates the potential of GigaGen’s machine learning

  • GlobeNewswire

    Deutsche Bank’s Depositary Receipts Virtual Investor Conference presentations now available for on-demand viewing

    NEW YORK, May 12, 2022 (GLOBE NEWSWIRE) -- Deutsche Bank today announced that the presentations from the May 10th and 11th Depositary Receipts Virtual Investor Conference (“dbVIC”) are now available for on-demand viewing. The event featured presentations from international companies with American Depositary Receipt (ADR) programs in the US. Representatives from participating companies based in China, Hong Kong, Germany, Portugal, South Africa, Spain and the UK presented their equity stories and

Advertisement
Advertisement